Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients.

MLA

Hiwarkar, P., et al. “Impact of Viral Reactivations in the Era of Pre-Emptive Antiviral Drug Therapy Following Allogeneic Haematopoietic SCT in Paediatric Recipients.” Bone Marrow Transplantation, vol. 48, no. 6, June 2013, pp. 803–08. EBSCOhost, https://doi.org/10.1038/bmt.2012.221.

APA

Hiwarkar, P., Gaspar, H. B., Gilmour, K., Jagani, M., Chiesa, R., Bennett-Rees, N., Breuer, J., Rao, K., Cale, C., Goulden, N., Davies, G., Amrolia, P., Veys, P., & Qasim, W. (2013). Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transplantation, 48(6), 803–808. https://doi.org/10.1038/bmt.2012.221

Chicago

Hiwarkar, P, H B Gaspar, K Gilmour, M Jagani, R Chiesa, N Bennett-Rees, J Breuer, et al. 2013. “Impact of Viral Reactivations in the Era of Pre-Emptive Antiviral Drug Therapy Following Allogeneic Haematopoietic SCT in Paediatric Recipients.” Bone Marrow Transplantation 48 (6): 803–8. doi:10.1038/bmt.2012.221.